Literature DB >> 4146457

Salicylazosulfapyridine in clinical practice.

P Goldman, M A Peppercorn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4146457

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

1.  The influence of bacterial gut hydrolysis on the fate of orally administered isonicotinuric acid in man.

Authors:  H G Boxenbaum; G S Jodhka; A C Ferguson; S Riegelman; T R MacGregor
Journal:  J Pharmacokinet Biopharm       Date:  1974-06

Review 2.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

Review 3.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

4.  Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.

Authors:  R P Chan; D J Pope; A P Gilbert; P J Sacra; J H Baron; J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

Review 5.  Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease.

Authors:  G Järnerot
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.